EXABLATE 4000 SYS004000-AA

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2017-08-29 for EXABLATE 4000 SYS004000-AA manufactured by Insightec, Ltd..

Event Text Entries

[83964943] *note: exablate 4000 is not indicated for use in the treatment of hypothalamic harmartoma (hh) under p150038. **note: evalution summary: relevant clinical background (patient age, gender, indication for treatment, description of treatment target, general status, other relevant clinical findings) female, (b)(6), treated for hypothalamic hamartoma (hh) epilepsy. She was operated twice in the past. Patient had a cyst dorsal to the target. Patient had previous craniotomy. Relevant treatment flow description treatment consisted of 12 sonications, target was the junction between the hypothalamus and the hamartoma. Maximal temperature that was reached at sonication no. 10 was 54? C at 4 mm away from the visual tract. All other sonications did not pass the t=51? C. Treatment analysis (adequate and inadequate treatment decisions and acts) as part of insightec standard of operation, the full treatment was reviewed in details including and not limited to this specific ae. As seen on the thermal images, the hot spot was smeared (elongated) in the anterior posterior direction and extended laterally. Areas beyond 50? C were always confined to the target and >5mm away from the visual tract; none of the sonications resulted in more than 52? C. As the spot was smeared, treatment was stopped after 12 sonications to avoid temperatures >48? C outside the target. In the 1 day post treatment t2w mr images there seems to be some hyperintensity in the treated area. This was the 1st hh treatment in (b)(6). The event may have been a result of the proximity of the target to the visual tract and specifically to edema resulted after the treatment.
Patient Sequence No: 1, Text Type: N, H10


[83964944] A (b)(6) female was treated with the exablate neuro system at the (b)(6) for hypothalamic hamartoma (hh) epilepsy. Two days post-treatment, the patient experienced a visual field cut in the lower half of the left eye with no decline in visual acuity. It was reported that event may be related to the pressure on the visual crossover and expansion of edema and swelling of the lesion itself observed on the mr images taken 1 day post treatment. Patient was treated with steroids and followed up with mr images before and after about 7 days. The solidified layer was well formed, and three clotting foci were created in the dwi image. Two weeks post treatment site reported that the patient has still visual field cut problem. They plan visual field examination in (b)(6) by ophthalmologist and an outpatient clinic visit in (b)(6) at (b)(6).
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number9615058-2017-00002
MDR Report Key6829279
Date Received2017-08-29
Date of Report2017-08-29
Date of Event2017-06-20
Date Facility Aware2017-06-25
Report Date2017-06-25
Date Reported to Mfgr2017-06-25
Date Mfgr Received2017-06-25
Date Added to Maude2017-08-29
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. IDAN COHEN
Manufacturer Street5 NACHUM HETH STREET P.O. BOX 2039
Manufacturer CityTIRAT CARMEL, ISRAEL 39120
Manufacturer CountryIS
Manufacturer Postal39120
Manufacturer G1INSIGHTEC, LTD
Manufacturer Street5 NACHUM HETH STREET P.O. BOX 2039
Manufacturer CityTIRAT CARMEL, ISRAEL 39120
Manufacturer CountryIS
Manufacturer Postal Code39120
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameEXABLATE 4000
Generic NameMR-GUIDED FOCUSED ULTRASOUND SYSTEM
Product CodePOH
Date Received2017-08-29
Model NumberEXABLATE 4000
Catalog NumberSYS004000-AA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerINSIGHTEC, LTD.
Manufacturer Address5 NACHUM HETH STREET P.O. BOX 2039 TIRAT CARMEL, ISRAEL 31290 IS 31290


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2017-08-29

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.